20 June 2013
Keywords: mylan, earnings, soar, fiscal, 2nd-qtr, strong, sales
Article | 12 November 2007
Strong sales of products like the painkiller fentanyl, a copy-cat version of Johnson & Johnson's Duragesic, helped drive USA-based
generics firm ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 November 2007
19 June 2013
© 2013 thepharmaletter.com